Deferasirox

Overview

Deferasirox is an iron chelator used to reduce chronic iron overload in patients who receive long-term blood transfusions. It binds to iron and allows its elimination from the body, thereby preventing damage to organs from excess iron deposition.

API suppliers (14)

Suppliers of Deferasirox backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• TAPI NL BV2 active DMF
• ALIVUS LIFE SCIENCES LTD1 active DMF
• PURE AND CURE HEALTHCARE PRIVATE LTDIndia1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• PURE AND CURE HEALTHCARE PRIVATE LTDIndia1 active DMF
• Piramal Pharma LimitedIndia1 active DMF
• Biocon LimitedIndia1 active DMF
• SYMED LABS LTDIndia1 active DMF
• MATRIX PHARMACORP PRIVATE LTD1 active DMF
• ALIVUS LIFE SCIENCES LTD1 active DMF
• ERREGIERRE SPAItaly
• APOTEX PHARMACHEM INC
• BACHEM INC

Patent & exclusivity (US)

Per the FDA Orange Book (84 approved US products), the latest listed US patent on Deferasirox expires 21 Nov 2034. Generic API sourcing typically opens up once these lapse.

Therapeutic areas